Methods and compositions involving miRNA and miRNA inhibitor molecules

Details for Australian Patent Application No. 2005333165 (hide)

International Classifications

Event Publications

14 June 2007 Assignment before Grant

Ambion, Inc. The application has been assigned to Asuragen, Inc. 2006

14 June 2007 PCT application entered the National Phase

PCT publication WO2006/137941 Priority application(s): WO2006/137941

19 July 2012 Application Accepted

Published as AU-B-2005333165

9 August 2012 Application for Amendment

The nature of the amendment is: Amend the name of the inventor to read Ford, Lance; Jarvis, Rich; Ovcharenko, Dmitriy; Brown, David; Byrom, Mike; Cheng, Angie; Kelnar, Kevin; Devroe, Eric and Slack, Frank J. . Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden Canberra ACT 2606 2006

9 August 2012 Alteration of Name

The name of the applicant has been altered to Asuragen, Inc.; Yale University 2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.